Stock NWRN NEWRON PHARMACEUTICALS S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Newron Pharmaceuticals S.p.A.

Equities

NWRN

IT0004147952

Market Closed - Swiss Exchange
Other stock markets
 11:31:59 2024-04-30 am EDT 		5-day change 1st Jan Change
8.21 CHF +7.46% Intraday chart for Newron Pharmaceuticals S.p.A. +17.29% +65.86%
01:00pm Newron Pharmaceuticals S.p.A. Announces Positive Top-line Results From Potentially Pivotal Phase II/III Study 008A With Evenamide in Schizophrenia Patients CI
Apr. 17 Newron Pharmaceuticals Appoints Margarita Chavez as Independent Board Member CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Newron Pharmaceuticals Appoints Margarita Chavez as Independent Board Member
CI
Newron Pharmaceuticals S.p.A. Appoints Margarita Chavez as Board Advisor
CI
Newron Pharmaceuticals S.P.A. Announces Marco Caremi, Executive Vice President Business Development Will Leave the Company as Per End of June 2023
CI
Newron Pharmaceuticals Promotes Finance VP to CFO
MT
Newron Pharmaceuticals S.p.A. Announces Resignation of Robert Leslie Holland as Non-Executive Member of the Board of Directors
CI
Newron Pharmaceuticals S.p.A. Announces Change in Board of Directors
CI
Newron Pharmaceuticals S.p.A Announces Management Changes
CI
Newron Pharmaceuticals S.p.A. Announces Board Appointments
CI
Newron Pharmaceuticals S.p.A. Appoints Roberto Consonni as Non Executive Director
CI
Newron Pharmaceuticals S.p.A. Announces Changes in Management Team, Effective as of May 31, 2012
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NWRN Stock
  4. News Newron Pharmaceuticals S.p.A.
  5. Insiders